DrugPatentWatch Database Preview
Uswm Company Profile
» See Plans and Pricing
What is the competitive landscape for USWM, and what generic and branded alternatives to USWM drugs are available?
USWM has four approved drugs.
Summary for Uswm
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Uswm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uswm | REVONTO | dantrolene sodium | INJECTABLE;INJECTION | 078378-001 | Jul 24, 2007 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Uswm | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 207032-001 | May 3, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-005 | Oct 28, 1986 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Uswm | LUCEMYRA | lofexidine hydrochloride | TABLET;ORAL | 209229-001 | May 16, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Uswm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-005 | Oct 28, 1986 | 3,935,267 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-002 | Approved Prior to Jan 1, 1982 | 3,935,267 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-001 | Approved Prior to Jan 1, 1982 | 3,982,021 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-001 | Approved Prior to Jan 1, 1982 | 3,935,267 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-004 | Approved Prior to Jan 1, 1982 | 3,982,021 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-003 | Approved Prior to Jan 1, 1982 | 3,982,021 | Start Trial |
| Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-004 | Approved Prior to Jan 1, 1982 | 3,935,267 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
